Bigger Jt

发表

Diuretic Therapy, Hypertension, and Cardiac Arrest

Bigger Jt, 1994 .

Why patients with congestive heart failure die: arrhythmias and sudden cardiac death.

Bigger Jt, 1987 .

Possible electrophysiological mechanisms for lethal arrhythmias accompanying myocardial ischemia and infarction.

Bigger Jt, Wit Al, 1975 .

Clinical aspects of trial design: What can we expect from the cardiac arrhythmia suppression trial?

Bigger Jt, 1990 .

Clinical use of antiarrhythmic drugs.

Bigger Jt, Heissenbuttel Rh, 1970 .

Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery

Bigger Jt, Bigger Jt, 1997 .

Arrhythmias and antiarrhythmic drugs.

Bigger Jt, Bigger Jt, 1972 .

Risk Stratification After Myocardial Infarction

Bigger Jt, 2020, Mayo Clinic Cardiology.

Digitalis toxicity: drug interactions promoting toxicity and the management of toxicity.

Bigger Jt, Strauss Hc, 1972, Seminars in drug treatment.

Clinical use of antiarrhythmic drugs.

Bigger Jt, Heissenbuttel Rh, 1970, Postgraduate medicine.

Diabetes and outcomes of coronary artery bypass graft surgery in patients with severe left ventricular dysfunction: results from The CABG Patch Trial database. The CABG Patch Trial Investigators and Coordinators.

J. Bigger, W. Whang, Bigger Jt, 2000, Journal of the American College of Cardiology.